Grass-Roots Lobbying

AUTHOR: Donald J. Barnes,p.12 Assuming the existence of a research funding crisis, and assuming such crisis cannot be solved by quality-based reallocation of funds, Eugene Garfield's commentary of April 29, 1991 [page 14] suggests meaningful action for scientists at the grass-roots level. Even so, there seems to be a misleading theme running through his editorial--that is, additional funds are required, according to Garfield, to combat animal rights zealots, rather than to fund research directl

Written byDonald Barnes
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

AUTHOR: Donald J. Barnes,p.12

Assuming the existence of a research funding crisis, and assuming such crisis cannot be solved by quality-based reallocation of funds, Eugene Garfield's commentary of April 29, 1991 [page 14] suggests meaningful action for scientists at the grass-roots level. Even so, there seems to be a misleading theme running through his editorial--that is, additional funds are required, according to Garfield, to combat animal rights zealots, rather than to fund research directly.

Science is a broad term, encompassing, but not limited to, animal-based research; in fact, such research is but a minor aspect of science. Advocates for nonhuman (and human) animals have no problem with public funds allocated for meaningful and ethical research, preferring these endeavors over many others, such as military funding and misguided World Bank development. Let's be perfectly honest: The credibility of scientists is waning, but because of the arrogance and fraudulent actions of scientists ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies